An open, multicenter, non-comparative, phase IV trial of efficacy and safety of Ketek (telithromycin) 800mg.

Trial Profile

An open, multicenter, non-comparative, phase IV trial of efficacy and safety of Ketek (telithromycin) 800mg.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Sep 2009

At a glance

  • Drugs Telithromycin (Primary)
  • Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 15 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top